Alembic Pharma JV Aleor Dermaceuticals gets USFDA EIR for Karakhadi facility

Written by Ruchika Sharma Published On 2020-05-08T14:25:53+05:30 | Updated On 8 May 2020 2:25 PM IST

Alembic Pharma JV Aleor Dermaceuticals gets USFDA EIR for Karakhadi facility

Gujrat: Aleor Dermaceuticals Ltd has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Formulation Facility at Karakhadi, Gujarat, India.

USFDA had inspected the Karakhadi facility from 6 th January 2020 to 8th January 2020.

Aleor Dermaceuticals Ltd. is a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. and Orbicular Pharmaceutical Technologies Pvt. Ltd.

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company headquartered in Gujarat.

Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world.

Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.

aleor-dermaceuticalsalembic-pharmaorbicular-pharmaceutical-technologieseirusfda

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751